【24h】

A prospective study of complications associated with cuffed, tunnelled haemodialysis catheters.

机译:前瞻性研究与袖带,隧道血液透析导管相关的并发症。

获取原文
获取原文并翻译 | 示例
           

摘要

BACKGROUND: Despite the US Dialysis Outcome Quality Initiative )DOQI( guidelines, for various reasons, increasing numbers of end-stage renal disease patients are becoming dependent on cuffed haemodialysis catheters (HCs) for chronic haemodialysis access. Their use is complicated by frequent failure due to thrombosis and catheter-related sepsis. In our unit, all HCs are put in place by the radiology department. METHODS: In a prospective study we looked at the outcome of all HCs over a three-year period, during which time 573 consecutive HCs were placed in 336 patients. Each line was followed individually until it was removed or until the end of the study. RESULTS: In a survival analysis of those HCs removed following HC failure, HC half-life was 312 days and one-year HC survival was 47.5%. The most frequent indications for HC removal were non-function (36.6%), clinical suspicion of line sepsis (16.4%) and patient death (14.4%). Using a Cox proportional hazards model, catheter number in a given patient and the presence of diabetes mellitus were found to be independent predictors of HC failure. The total incidence of HC-related sepsis was 1.3 episodes/1000 catheter days. The probability of developing bacteraemic HC-related sepsis was 27.5% at one year. CONCLUSIONS: Less than half of the HCs were removed electively because of availability of a more permanent mode of renal replacement, thereby illustrating the level of dependence that has developed on them as permanent access. Consequently, their limitations (infection and malfunction) are placing an ever increasing burden on the healthcare services.
机译:背景:尽管有美国透析结果质量倡议(DODIA)指南,但由于各种原因,越来越多的终末期肾病患者开始越来越多地依赖袖带式血液透析导管(HCs)进行慢性血液透析,但由于频繁的失败而使他们的使用变得复杂方法:在一项前瞻性研究中,我们研究了三年内所有HC的结局,在此期间连续573例HC结果:在对HC衰竭后被去除的HC进行生存分析时,HC的半衰期为312天,HC的生存期为一年,共336名患者被放置,每行单独随访直至其被移除或直至研究结束。率为47.5%。HC去除的最常见指征是无功能(36.6%),临床怀疑为败血症(16.4%)和患者死亡(14.4%)。使用Cox比例风险模型,特定患者和糖尿病的存在是HC失败的独立预测因子。 HC相关性败血症的总发生率为1.3次发作/每1000导管天。一年内出现与细菌性HC相关的败血症的可能性为27.5%。结论:由于可获得更永久的肾脏替代治疗方式,因此有选择性地去除了不到一半的HC,从而说明了对它们的依赖程度已经成为永久性获取途径。因此,它们的局限性(感染和故障)给医疗保健服务带来了越来越大的负担。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号